Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference42 articles.
1. Ahmed I, Ferro A, Cohler A, Langenfeld J, Surakanti SG, Aisner J et al (2015) Impact of metformin use on survival in locally-advanced, inoperable non-small cell lung cancer treated with definitive chemoradiation. J Thorac Dis 7(3):346–355
2. Arrieta O, Varela-Santoyo E, Soto-Perez-de-Celis E, Sánchez-Reyes R, De la Torre-Vallejo M, Muñiz-Hernández S et al (2016) Metformin use and its effect on survival in diabetic patients with advanced non-small cell lung cancer. BMC Cancer 16:633
3. Arrieta O, Barrón F, Padilla MS, Avilés-Salas A, Ramírez-Tirado LA, Arguelles Jiménez MJ et al (2019) Effect of metformin plus tyrosine kinase inhibitors compared with tyrosine kinase inhibitors alone in patients with epidermal growth factor receptor-mutated lung adenocarcinoma: a phase 2 randomized clinical trial. JAMA Oncol 5(11):e192553
4. Bugge AS, Lund MB, Valberg M, Brustugun OT, Solberg S, Kongerud J (2018) Cause-specific death after surgical resection for early-stage non-small-cell lung cancer. Eur J Cardiothorac Surg 53(1):221–227
5. Burns PB (2011) The levels of evidence and their role in evidence-based medicine. Plast Reconstr Surg 128(1):305–310
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献